Liver injury during antituberculosis treatment: An 11-year study
- 31 August 1996
- journal article
- Published by Elsevier BV in Tubercle and Lung Disease
- Vol. 77 (4), 335-340
- https://doi.org/10.1016/s0962-8479(96)90098-2
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Hepatotoxicity Associated With Acetaminophen Usage in Patients Receiving Multiple Drug Therapy for TuberculosisChest, 1994
- Isoniazid-associated Hepatitis Deaths: A Review of Available InformationAmerican Review of Respiratory Disease, 1992
- Acetaminophen, Isoniazid, and Hepatic ToxicityAnnals of Internal Medicine, 1991
- USPHS Tuberculosis Short-Course Chemotherapy Trial 21: Effectiveness, Toxicity, and AcceptabilityAnnals of Internal Medicine, 1990
- Consensus meetings on: Causality assessment of drug-induced liver injuryJournal of Hepatology, 1988
- Short-course ChemotherapyChest, 1981
- Risk Factors for Isoniazid (INH)-Induced Liver DysfunctionJournal of Clinical Gastroenterology, 1981
- Toxic Effects of Isoniazid in Tuberculosis ChemoprophylaxisJAMA, 1979
- The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamideTubercle, 1977
- Toxicity from rifampicin plus isoniazid and rifampicin plus ethambutol therapyTubercle, 1971